The search strategy targeted studies involving GLP-1 receptor agonists (e.g., exenatide, liraglutide, dulaglutide, lixisenatide, benaglutide, loxenatide, semaglutide) and multi-target receptor agonists (e.g., tirzepatide), focusing on gastrointestinal adverse events (e.g., nausea, vomiting, diarrhea, constipation, dyspepsia, and reduced appetite) in patients with type 2 diabetes mellitus (T2DM) (Supplementary Material)
The liver works harder without keeping pace
:
One of the best things you can do on your menopause journey is team up with a healthcare professional, like a Midi Health clinician, to go over all your options and determine the best treatment for your lifestyle, medical history, symptomsand budget
Plant Res
If required, we take care of the prior authorization process, allowing a seamless transition to starting your Wegovy treatment